These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15841777)

  • 21. Does Prostate Size Predict the Development of Incident Lower Urinary Tract Symptoms in Men with Mild to No Current Symptoms? Results from the REDUCE Trial.
    Simon RM; Howard LE; Moreira DM; Roehrborn C; Vidal AC; Castro-Santamaria R; Freedland SJ
    Eur Urol; 2016 May; 69(5):885-91. PubMed ID: 26724841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship among symptom score, prostate volume, and urinary flow rates in 543 patients with and without benign prostatic hyperplasia.
    Sciarra A; D'Eramo G; Casale P; Loreto A; Buscarini M; Di Nicola S; Seccareccia F; Di Silverio F
    Prostate; 1998 Feb; 34(2):121-8; discussion 129. PubMed ID: 9465943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.
    Stief CG; Porst H; Neuser D; Beneke M; Ulbrich E
    Eur Urol; 2008 Jun; 53(6):1236-44. PubMed ID: 18281145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of increased urine brain derived neurotrophic factor with lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Wang LW; Li JL; Yu Y; Xiao RH; Huang HW; Kuang RR; Hai B
    J Huazhong Univ Sci Technolog Med Sci; 2017 Aug; 37(4):531-535. PubMed ID: 28786061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Guide dedicated to general practitioner for the management of lower urinary tract symptoms related to benign prostatic hyperplasia].
    Descazeaud A; Barry Delongchamps N; Cornu JN; Azzouzi AR; Buchon D; Benchikh A; Coloby P; Dumonceau O; Fourmarier M; Haillot O; Lebdai S; Mathieu R; Misrai V; Saussine C; de La Taille A; Robert G;
    Prog Urol; 2015 Jun; 25(7):404-12. PubMed ID: 25841758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urological disorders in men: urinary incontinence and benign prostatic hyperplasia.
    Miller SW; Miller MS
    J Pharm Pract; 2011 Aug; 24(4):374-85. PubMed ID: 21984774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is periurethral calcification associated with urinary flow rate and symptom severity in men with lower urinary tract symptoms-benign prostatic hyperplasia? A retrospective review.
    Han JH; Kwon JK; Lee JY; Kang DH; Choi HC; Lee JS; Cho KS
    Urology; 2015 May; 85(5):1156-1161. PubMed ID: 25818911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tadalafil Improves Symptoms, Erectile Function and Quality of Life in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (KYU-PRO Study).
    Takahashi R; Miyazato M; Nishii H; Sumino Y; Takayama K; Onzuka M; Oshiro T; Saito S; Fujimoto N; Mimata H; Eto M
    Low Urin Tract Symptoms; 2018 Jan; 10(1):76-83. PubMed ID: 29341501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7).
    Rosen R; Altwein J; Boyle P; Kirby RS; Lukacs B; Meuleman E; O'Leary MP; Puppo P; Robertson C; Giuliano F
    Eur Urol; 2003 Dec; 44(6):637-49. PubMed ID: 14644114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impacts of histological prostatitis on sexual function and lower urinary tract symptoms in patients with benign prostatic hyperplasia.
    Wang GC; Zheng JH; Yang B; Che JP; Yan Y; Geng J; Liu M; Huang JH; Xia SQ; Peng B
    Urology; 2013 Nov; 82(5):1094-7. PubMed ID: 23915513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive patient evaluation for benign prostatic hyperplasia.
    Jepsen JV; Bruskewitz RC
    Urology; 1998 Apr; 51(4A Suppl):13-8. PubMed ID: 9586591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Benign prostatic hyperplasia and its treatment: impact on quality of life and sexual function].
    Castro-Díaz D; Díaz-Cuervo H; Pérez M
    Actas Urol Esp; 2013 Apr; 37(4):233-41. PubMed ID: 23246106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survey on benign prostatic hyperplasia distribution and treatment patterns for men with lower urinary tract symptoms visiting urologists at general hospitals in Korea: a prospective, noncontrolled, observational cohort study.
    Lee SH; Chung BH; Kim CS; Lee HM; Kim CI; Yoo TK; Lee KS; Park KS; Byun SS; Yoon BI; Kim SW; Lee JY
    Urology; 2012 Jun; 79(6):1379-84. PubMed ID: 22503769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging.male (MSAM-7)].
    Rosen R; Altwein J; Boyle P; Kirby RS; Lukacs B; Meuleman E; O'Leary MP; Puppo P; Chris R; Giuliano F
    Prog Urol; 2004 Jun; 14(3):332-44. PubMed ID: 15373175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between erectile dysfunction and lower urinary tract symptoms due to benign prostatic hyperplasia in Nigerian men.
    Ikuerowo SO; Akindiji YO; Akinoso OA; Akinlusi FM; Esho JO
    Urol Int; 2008; 80(3):296-9. PubMed ID: 18480635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UK.
    Speakman M; Kirby R; Doyle S; Ioannou C
    BJU Int; 2015 Apr; 115(4):508-19. PubMed ID: 24656222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study.
    Roehrborn CG; Siami P; Barkin J; Damião R; Major-Walker K; Nandy I; Morrill BB; Gagnier RP; Montorsi F;
    Eur Urol; 2010 Jan; 57(1):123-31. PubMed ID: 19825505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association of endothelial nitric oxide synthase (eNOS) G894T gene polymorphism with responsiveness to a selective α1 -blocker in men with benign prostatic hyperplasia related lower urinary tract symptoms.
    Lee YC; Juan YS; Liu CC; Bao BY; Wang CJ; Wu WJ; Huang CN; Huang SP
    BJU Int; 2016 Aug; 118(2):313-9. PubMed ID: 26940040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
    Kaplan SA; Roehrborn CG; Chancellor M; Carlsson M; Bavendam T; Guan Z
    BJU Int; 2008 Nov; 102(9):1133-9. PubMed ID: 18510659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired Sleep Quality is Associated With More Significant Lower Urinary Tract Symptoms in Male Shift Workers.
    Scovell JM; Pastuszak AW; Slawin J; Badal J; Link RE; Lipshultz LI
    Urology; 2017 Jan; 99():197-202. PubMed ID: 27639796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.